UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000027874
Receipt number R000031940
Scientific Title Evaluation of the usefulness of preoperative 3D simmulation in partial nephrectomy -using ICG ( indocyanine green ) fluorescence Imaging
Date of disclosure of the study information 2017/06/22
Last modified on 2023/06/28 15:58:14

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of the usefulness of preoperative 3D simmulation in partial nephrectomy
-using ICG ( indocyanine green ) fluorescence Imaging

Acronym

ICG fluorescence imaging in partial nephrectomy

Scientific Title

Evaluation of the usefulness of preoperative 3D simmulation in partial nephrectomy
-using ICG ( indocyanine green ) fluorescence Imaging

Scientific Title:Acronym

ICG fluorescence imaging in partial nephrectomy

Region

Japan


Condition

Condition

renal tumor

Classification by specialty

Urology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the usefulness of 3D simulation in partial nephrectomy by using ICG fluorescence Imaging

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

validation of the expected feeding artery

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Medicine

Interventions/Control_1

intravenous administration of ICG ( indocyanine green)

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) PS 0 or 1
2) 20 years old over at the acquisition of the consent
3) no severe abnormality of cardioplumonary, liver and renal function
4) contrast CT is performed
5) no contraindication of administration of ICG
6) the written consent of the patient has been obtained for this clinical trial

Key exclusion criteria

When there is request of the cancellation

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Tetsuya
Middle name
Last name Yoshida

Organization

Shiga university of medical science

Division name

department of urology

Zip code

520-2192

Address

Seta Tsukinowa-cho, Otsu City,Shiga,JAPAN

TEL

077-548-2273

Email

hquro@belle.shiga-med.ac.jp


Public contact

Name of contact person

1st name Tetsuya
Middle name
Last name Yoshida

Organization

Shiga university of medical science

Division name

department of urology

Zip code

520-2192

Address

Seta Tsukinowa-cho, Otsu City,Shiga,JAPAN

TEL

077-548-2273

Homepage URL


Email

hquro@belle.shiga-med.ac.jp


Sponsor or person

Institute

Shiga university of medical science

Institute

Department

Personal name



Funding Source

Organization

Shiga university of medical science

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Department of Urology Shiga University of Medical science

Address

Seta Tukinowa chou, Otsu, Shiga, Japan

Tel

+819078803956

Email

hquro@belle.shiga-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 06 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2016 Year 10 Month 25 Day

Date of IRB

2016 Year 10 Month 25 Day

Anticipated trial start date

2016 Year 11 Month 16 Day

Last follow-up date

2023 Year 06 Month 28 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 06 Month 22 Day

Last modified on

2023 Year 06 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031940


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name